|
|
 |
| |
|
Home > Drug Companies > Elan Pharmaceuticals
Elan Pharmaceuticals
Elan Corporation, is a neuroscience-based biotechnology company that is focused on discovering, developing, manufacturing and marketing advanced therapies in neurology, autoimmune diseases, and severe pain.
The U.S. Food and Drug Administration approved Natalizumab, formerly referred to as Antegren, as treatment for relapsing forms of multiple sclerosis to reduce the frequency of clinical relapses. The European Commission granted Elan Pharmaceuticals. marketing approval for Prialt ziconotide for the treatment of severe, chronic pain in patients who require intrathecal IT analgesia.
Elan's focus on improving the health of patients suffering from chronic and debilitating conditions is exemplified by its breakthrough research program in Alzheimer's disease, where it has developed three novel therapeutic approaches are Immunotherapy In collaboration with Wyeth, this approach targets the clearance of beta amyloid, the peptide responsible for the build-up of amyloid plaques in the brain, Beta secretase inhibitors Targets a distinct enzyme associated with the production of beta amyloid, Gamma secretase inhibitors Targets a distinct enzyme associated with the production of beta-amyloid In neurology, Elan is focused on building upon its breakthrough research and extensive experience in the area of neuropathology based disorders. In addition to Alzheimer’s disease, Elan is also studying other neurodegenerative diseases, such as Parkinson's disease.
In autoimmune diseases, Elan’s primary emphasis is studying and developing ways to provide disease modifying therapies for a wide range of diseases. Their mission governs the way they do business, the research they do, the products they develop, the way they train their employees and the allocation of their financial resources. The firm is a human health care company that seeks to discover and develop innovative therapies that can satisfy unmet medical needs and contribute to the health and well being of people worldwide.
Back to Drug Companies
|
|
|
|
|
|
|
|